Skip to content
S856Senate2023-2024 SessionSame asA988

End Digital Drug Program

Official title

“Repeals provisions relating to prescription digital therapeutics”

Sponsor Pete HarckhamSD-40
Status
Senate Floor Calendar
Impact
4/10
Low
Outcome
Companion signed

Bill progress

Signed via A988

What's happening

This bill repeals a 2022 law requiring New York to determine federal funding eligibility for certain prescription digital therapeutics.

Why it matters

  1. Potentially slows or halts state-level exploration of Medicaid/insurance funding for prescription digital therapeutics. (such as app-based treatments for mental health or substance use), which could affect access for patients who might have benefited from these technologies.

  2. Signals a shift in legislative priorities or skepticism about the value, cost-effectiveness, or readiness of prescription digital therapeutics. in New York’s public health system, possibly reflecting concerns about evidence, regulation, or budget impact.

  3. May delay or complicate future efforts to secure federal matching funds for digital health tools. by removing the requirement to assess and prepare for such funding, potentially putting New York behind other states in digital health innovation.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

End Digital Drug Program

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Pete Harckham

Senator · Senate District 40

Chair, Environmental Conservation

No co-sponsors yet.

History

  1. Substituted by A988
  2. Ordered to third reading cal.65
  3. Referred to rules

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A988Assembly

Repeal Digital Therapy Coverage

Signed by Governor · Sponsor Linda Rosenthal

Impact 4 · LowSigned into law

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

856

2023-2024 Regular Sessions

IN SENATE

January 6, 2023

Introduced by Sen. HARCKHAM -- read twice and ordered printed, and when printed to be committed to the Committee on Rules

AN ACT to repeal section 1 of a chapter of the laws of 2022 relating to determining whether the state can claim federal financial participation for coverage of and payment for certain prescription digital therapeutics, as proposed in legislative bills numbers S. 559 and A.

3642, in relation to prescription digital therapeutics

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Section 1 of a chapter of the laws of 2022 relating to determining whether the state can claim federal financial participation for coverage of and payment for certain prescription digital therapeutics, as proposed in legislative bills numbers S. 559 and A. 3642, is REPEALED.

§ 2. This act shall take effect on the same date and in the same manner as a chapter of the laws of 2022 relating to determining whether the state can claim federal financial participation for coverage of and payment for certain prescription digital therapeutics, as proposed in legislative bills numbers S. 559 and A. 3642, takes effect.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD04214-01-3

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to repeal section 1 of a chapter of the laws of 2022 relating to determining whether the state can claim federal financial participation for coverage of and payment for certain prescription digital therapeu- tics, as proposed in legislative bills numbers S. 559 and A. 3642, in relation to prescription digital therapeutics

Purpose

This is a chapter amendment that makes changes to provisions of L.2022, c. , relating to determining whether the state can claim federal participation for coverage of and payment for certain prescription digital therapeutics.

Summary of provisions

Changes included in this Chapter strike the statement of legislative intent. The remainder of the underlying legislation is unchanged.

The underlying legislation directs the Department of Health to seek guidance from the Centers for Medicare & Medicaid Services (CMS) on if the state can claim federal financial participation for certain prescription digital therapeutics to treat substance use and opioid use disorders.

Digital therapeutics deliver software-generated therapeutic inter- ventions directly to patients to prevent, manage, or treat a medical disorder or disease and include interventions such as the digital deliv- ery of physical exercises, behavioral therapy, and education for chronic back pain patients, and a personalized digital program to help people prevent the onset of diabetes and other chronic diseases.

Existing law

None

Justification

This legislation is a negotiated change to the underlying Chapter.

Legislative history

Chapter amendment to Chapter of the Laws of 2022. S.559 and A.3642 both passed the Senate and Assembly in.

Fiscal implications

None

Effective date

This act shall take effect on the same date and in the same manner as Chapter of the Laws of 2022, proposed as legislative bill numbers S.559 and, A.3642; immediately.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.